Mining the CRBN target space redefines rules for molecular glue-induced neosubstrate recognition

Georg Petzold1, Pablo Gainza1, Stefano Annunziato1

  • 1Monte Rosa Therapeutics Inc, Boston, MA, USA.

Science (New York, N.Y.)
|July 3, 2025
PubMed
Summary

Molecular glues targeting CRL4CRBN reprogram specificity to degrade proteins. This study expands the cereblon (CRBN) target space, identifying new recognition rules and over 1600 potential neosubstrates for drug development.